Skip to content
Friday, November 13, 2026
NewsCentralPlus UK

Zimbabwe Rejects ‘One-Sided’ US Healthcare Assistance Agreement Because of Information Apprehensions

Health aid illustration
The proposed US financial assistance was intended for initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

The nation of Zimbabwe has declined a major US healthcare agreement worth $367m (272 million pounds) spanning five years because of Washington's insistence on sensitive information.

This rejection was revealed after a government memo from December was disclosed, which showed Head of State Emmerson Mnangagwa felt the arrangement was "skewed".

A government spokesman later explained that the US was demanding access to health data for scientific study and commercial gain but refused to guarantee the benefits from future treatments.

"We are forced to start the challenging and unfortunate process of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had provided over $1.9bn in health funding to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has urged further negotiations to reach a deal agreeable to both sides so the country's vital HIV treatment initiative can proceed.

Wider Background

This development comes after a comparable situation in Kenya, where a high court suspended a related health funding agreement after legal challenges were filed about the safety of Kenyans' medical information.

Since resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.

The agency had managed assistance for the US government, but Trump argued its spending was "inefficient" and his administration was pursuing direct bilateral deals to boost transparency and responsibility.

According to statements, 16 African countries have so far agreed to similar health pacts, constituting over $18.3bn in committed funds.

Details of the Declined Deal

The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We believe this cooperation could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded programmes," the Ambassador said.

However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".

"Zimbabwe was being asked to provide its biological resources and data for a long time, without any corresponding assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.

"Effectively, our nation would provide the raw materials for medical research without any assurance that the resulting innovations would be accessible to our people if a future disease outbreak emerge."

National Interest and International Frameworks

He also said that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting systems already set up through the international organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to manage future global health emergencies.

"This mechanism is designed to ensure that when a country provides its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to develop them."

Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We welcome continued dialogue with our US partners on how future collaboration might be structured in a way that respects the independence and dignity of each country."

Health Experts Response

Medical experts stated it recognised the official position, but recommended that negotiations should continue given that much of the country's HIV programmes depended on international support.

"In cases where technical issues exist, such as those relating to information security or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," it added.

The situation underscores the ongoing challenges between receiving much-needed foreign assistance and safeguarding local interests in an increasingly data-driven world.

The writer

John Griffin

Award-winning journalist with over 15 years of experience covering UK politics and international affairs, known for insightful reporting.

NewsCentralPlus UK

Type to search articles.